Clinical Trials Logo

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

NCT number NCT04290130
Other study ID # 844668
Secondary ID
Status Enrolling by invitation
Phase Early Phase 1
First received
Last updated
Start date September 15, 2019
Est. completion date May 31, 2024

Study information

Verified date October 2023
Source University of Pennsylvania
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Understanding speech is one of the most important functions of the human brain. We use information from both the auditory modality (the voice the of person we are talking to) and the visual modality (the facial movements of the person we are talking to) to understand speech. We will use intracranial encephalography to study the organization and operation of the brain during audiovisual speech perception.


Recruitment information / eligibility

Status Enrolling by invitation
Enrollment 100
Est. completion date May 31, 2024
Est. primary completion date May 31, 2024
Accepts healthy volunteers No
Gender All
Age group 21 Years to 65 Years
Eligibility Inclusion Criteria: - must be undergoing neurosurgery for the treatment of a brain disorder Exclusion Criteria: - must have corrected-to-normal vision and hearing

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Measurement of brain activity using electrodes.
We will present audiovisual speech and record neural responses.

Locations

Country Name City State
United States University of Pennsylvania Philadelphia Pennsylvania

Sponsors (3)

Lead Sponsor Collaborator
University of Pennsylvania Baylor College of Medicine, Columbia University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Measurement of neural activity The name of the measurement is the broadband high-frequency activity (BHA) in the brain in response to audiovisual speech. The unit of measure is % increase in power from pre-stimulus baseline. The name of the measurement tool is intracranial EEG, recordings of the raw voltage signal from each electrode implanted in the brain. The voltage-by-time signal will be converted to spectral space using a wavelet transform, and the magnitude of the power between 70 and 150 Hz inclusive in a time window between 0 ms and 500 ms after stimulus onset will be calculated. During the procedure.
See also
  Status Clinical Trial Phase
Recruiting NCT05653999 - Assessing Speech Perception and Amplification Benefit During Infancy
Completed NCT04473729 - Improving Perception of Speech in Noise in Children With Communication Disorders N/A
Not yet recruiting NCT06152211 - Music-Based Interventions, Aging, Alzheimer's Disease N/A
Recruiting NCT04762043 - MyoVoice to Restore Natural, Hands-free Communication to Individuals With Vocal Impairments N/A
Completed NCT04135105 - Lexical Tone Perception in Tone language--a fMRI Study
Recruiting NCT06237790 - A Comparative Analysis of Speech Perception Between Cochlear Implant Patients and DFNB9 Patients Receiving Gene Therapy